Sore throat resident survival guide (pediatrics)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Sore throat resident survival guide (pediatrics) Microchapters |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Do's |
Don'ts |
Overview
This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Bacteria
- Streptococcus( group A beta-haemolytic )
- Haemophilus influenzae
- Moraxella catarrhalis
viruses[1]
- Rhinovirus.
- coronavirus.
- respiratory syncytial virus.
- metapneumovirus.
- Epstein–Barr virus.
chemical irritation[1]
- nasogastric tubes.
- smoke.
FIRE: Focused Initial Rapid Evaluation
Table 1
Clinical signs and symptoms of GABSH pharingitis , their sensitivity and specificity [5]
Symptoms and Clinical Findings | Sensitivity (%) | Specificity (%) |
---|---|---|
Absence of cough | 51-79 | 36-68 |
| ||
Anterior cervical nodes swollen or enlarged | 55-82 | 34-73 |
| ||
Headache | 48 | 50-80 |
| ||
Myalgia | 49 | 60 |
| ||
Palatine petechiae | 7 | 95 |
| ||
Pharyngeal exudates | 26 | 88 |
| ||
Fever >38°C | 22-58 | 52-92 |
| ||
Tonsillar exudate | 36 | 85 |
Table 2
Clinical Score for GABSH pharyngitis.
Reference | Clinical signs and symptoms | Sensibility (%) | Specificity (%) |
---|---|---|---|
[37] | Recent exposure to GABHS, pharyngeal exudate, enlarged or tender cervical nodes, fever | 55 | 74 |
| |||
[38] | Season, age, white cells count, fever, absence of cough, enlarged cervical nodes, tonsillar exudate or swelling | 68 | 85 |
| |||
[39] | Swollen and tender anterior cervical nodes, tonsillar exudate | 84 | 40 |
| |||
[40] | Fever, cervical nodes enlargement, tonsillar exudate or swelling or hypertrophy, Absence of cough | 63 | 67 |
| |||
[41] | Season, age, fever, enlarged cervical nodes, tonsillar exudate or swelling or hypertrophy, absence of cough or rhinitis or conjunctivitis | 22 | 93 |
| |||
[42] | Tonsillar hypertrophy, enlarged cervical nodes, absence of rhinitis, scarlet fever rash | 18 | 97 |
Table 3
Table 3
Centor Score [24].
Clinical criteria | Points |
---|---|
Absence of cough | 1 |
| |
Swollen and tender anterior cervical nodes | 1 |
| |
Temperature > 38°C | 1 |
| |
Tonsillar exudate or swelling | 1 |
| |
Age 3 to 14 years | 1 |
| |
Age 15 to 44 years | 0 |
| |
Age 45 years and older | -1 |
Complete Diagnostic Approach"portal.nnpbc.com" (PDF).
• Rapid strep test (if available)
• Throat swab for culture and sensitivity
• If the child is greater than 2 years old, culture the throat before treatment or do rapid Strep antigen test (if available); if negative, do throat culture.
• Monospot if suspect vira
Treatment
penicillin is first choice treatment, since GABHS remains universally susceptible to penicillin. Although penicillin V is the drug of choice, ampicillin or amoxicillin are good taste, represent a suitable option in children.
Table 4
Therapeutic options for GABHS pharyngitis recommended by American Hearth Association and American Academy of Pediatrics AAP [13,4].
Drug | Dose | Duration |
---|---|---|
Penicillins | ||
| ||
Penicillin V (oral) | • Children <27 kg: 400 000 U (250 mg) 2 to 3 times daily ;
• Children >27 kg, adolescents, and adults: 800 000 (500 mg) 2 to 3 times daily |
10 days |
| ||
Amoxicillin (oral) | 50 mg/kg once daily (maximum 1 g) | 10 days |
| ||
Benzathin Penicillin G (intramuscular) | • Children <27 kg: 600 000 U (375 mg);
• Children >27 kg, adolescents, and adults: 1 200 000 U (750 mg) |
Once |
| ||
For individuals allergic to penicillin | ||
| ||
Narrow-spectrum cephalosporin (cephalexin, cefadroxil) (oral)* | Variable | 10 days |
| ||
Clindamycin (oral) | 20 mg/kg per day divided in 3 doses (maximum 1.8 g/d) | 10 days |
| ||
Azithromycin (oral) | 12 mg/kg once daily (maximum 500 mg) | 5 days |
| ||
Clarithromycin (oral) | 15 mg/kg per day divided BID (maximum 250 mg BID) | 10 days |
* Patients with immediate or type I hypersensitivity to penicillin should not be treated with a cephalosporin [4].
Do's
- The content in this section is in bullet points.
Don'ts
- The content in this section is in bullet points.